Evidence map›Paper›PMID 42835420›Full record

ReviewFrontiers in psychiatry2026

The application of AI-driven digital phenotyping and interventions in neuropsychiatric disorders.

Yuhan Liu, D Logan Lu, Yating Hong, Lianting Hu, Hui Tang, Yaping Cheng, Yongshang Yu, Xuntao Yin, Huimin Xia, Long Lu

Abstract readReview
In one paragraph

Review in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuhan LiuCollege of Life Sciences, Wuhan University, Wuhan, China.
D Logan LuSchool of Information Management, Wuhan University, Wuhan, China.
Yating HongSchool of Information Management, Wuhan University, Wuhan, China.
Lianting HuData Center, Wuhan Children's Hospital, Wuhan, China.
Hui TangDepartment of Clinical Data Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
Yaping ChengSchool of Information Management, Wuhan University, Wuhan, China.
Yongshang YuDepartment of Clinical Data Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
Xuntao YinDepartment of Pediatric Rehabilitation, Guizhou Provincial Rehabilitation Hospital, Guiyang, China.
Huimin XiaDepartment of Clinical Data Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
Long LuSchool of Information Management, Wuhan University, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial intelligence (AI) is increasingly influencing the management of neuropsychiatric disorders, extending its role beyond assistive diagnosis toward adaptive intervention and individualized disease management. Digital phenotyping enables continuous assessment of multimodal behavioral and biological signals, allowing neuropsychiatric disorders to be modeled as dynamic rather than static processes. This review summarizes current AI-driven approaches for neuropsychiatric assessment and intervention, including computer vision-based behavioral analysis, wearable sensing, neuroimaging biomarkers, digital therapeutics, virtual reality, social robotics, and brain-computer interfaces. We further discuss emerging closed-loop frameworks that integrate real-time state estimation with adaptive intervention strategies, shifting neuropsychiatric AI from passive observation toward continuous therapeutic optimization. Despite rapid progress, integration between phenotyping and intervention remains limited, and most closed-loop systems are still confined to experimental settings. Key challenges include multimodal representation, interpretability, generalizability across populations and devices, and translation into real-world clinical workflows. We argue that the primary bottleneck in AI-driven neuropsychiatry is no longer prediction accuracy alone, but the ability to connect continuous patient-state estimation with clinically meaningful adaptive action. Finally, we outline future directions toward clinically grounded, human-AI collaborative neuropsychiatric systems.

Indexed as

artificial intelligenceclosed-loop systemsdigital mental healthdigital phenotypingneuropsychiatric disorderspersonalized intervention

Identifiers

PMID42835420
PMCPMC13635884

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.